These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 6418807

  • 1. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H, Hirata R.
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [Abstract] [Full Text] [Related]

  • 2. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R, Suzuki M, Yabe T, Hamaguchi H, Maeda H.
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [Abstract] [Full Text] [Related]

  • 3. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H, Hirata R, Okuyama M, Thompson A, Tohyama H.
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [Abstract] [Full Text] [Related]

  • 4. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5.
    Karr RW, Kannapell CC, Stein JA, Gebel HM, Mann DL, Duquesnoy RJ, Fuller TC, Rodey GE, Schwartz BD.
    J Immunol; 1982 Apr; 128(4):1809-18. PubMed ID: 6174616
    [Abstract] [Full Text] [Related]

  • 5. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G, Giles RC, Ball EJ, Hurley CK, Capra JD, Stastny P.
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [Abstract] [Full Text] [Related]

  • 6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T, Tsukamoto K, Hirayama K, Nishimura Y, Takenouchi T, Aizawa M, Sasazuki T.
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [Abstract] [Full Text] [Related]

  • 7. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T, Schwenzer J, Silver J, Winchester R.
    J Immunol; 1986 Aug 01; 137(3):934-40. PubMed ID: 2424991
    [Abstract] [Full Text] [Related]

  • 8. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E, Hénin Y, Sterkers G, Masset M, Fauchet R, Lévy JP.
    J Immunol; 1986 Jun 01; 136(11):3961-7. PubMed ID: 2422266
    [Abstract] [Full Text] [Related]

  • 9. Human B cell alloantigens: expression of MB and MT determinants.
    Markert ML, Cresswell P.
    J Immunol; 1982 May 01; 128(5):2004-8. PubMed ID: 6174619
    [Abstract] [Full Text] [Related]

  • 10. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW, Flomenberg N, Horibe K, Winchester R, Radka SF, Dupont B.
    J Immunol; 1986 Oct 15; 137(8):2618-26. PubMed ID: 2428870
    [Abstract] [Full Text] [Related]

  • 11. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
    De Kretser TA, Crumpton MJ, Bodmer JG, Bodmer WF.
    Eur J Immunol; 1982 Jul 15; 12(7):600-6. PubMed ID: 6811289
    [Abstract] [Full Text] [Related]

  • 12. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T, Suzuki M, Satake M, Juji T, Hamaguchi H.
    Immunogenetics; 1984 Jul 15; 20(2):155-67. PubMed ID: 6205988
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
    Giles RC, Hurley CK, Capra JD.
    J Immunol; 1984 Jul 15; 133(1):1-3. PubMed ID: 6609970
    [Abstract] [Full Text] [Related]

  • 15. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
    Bontrop RE, Schreuder GM, Elferink DG, Mikulski MM, Geerse R, Giphart MJ.
    J Immunol; 1986 Jul 01; 137(1):211-6. PubMed ID: 3486913
    [Abstract] [Full Text] [Related]

  • 16. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW, Lipman LK, Alber C, Koning F, Goeken NE.
    J Immunol; 1985 Oct 01; 135(4):2642-6. PubMed ID: 2411807
    [Abstract] [Full Text] [Related]

  • 17. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM, Moriuchi J, Winchester R, Silver J.
    Hum Immunol; 1983 Sep 01; 8(1):53-63. PubMed ID: 6195135
    [Abstract] [Full Text] [Related]

  • 18. Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2.
    Hirayama K, Nishimura Y, Tsukamoto K, Sasazuki T.
    J Immunol; 1986 Aug 01; 137(3):924-33. PubMed ID: 2424990
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.